Warsaw-based OrthoPediatrics Corp. (Nasdaq: KIDS) is announcing a third quarter net loss of $4.5 million, compared to a $2.6 million loss during the same period a year ago.
The manufacturer of orthopedic devices for children says it generated total revenue of $22.2 million for Q3, compared to $20.7 million a year earlier.
Chief Executive Officer Mark Throdahl says the COVID-19 pandemic continues to pose unprecedented challenges.
“During the quarter, the company continued to navigate the pandemic environment confidently, delivering overall revenue growth and improved EBITDA,” said Throdahl. “OrthoPediatrics remains focused on maintaining its positive momentum into the remainder of 2020 and into next year.”
To view the full earnings report, click here.